Navigation Links
Pearl Therapeutics' Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
Date:9/26/2011

to optimize the treatment of COPD.

About Pearl Therapeutics

Pearl Therapeutics is a privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease and asthma. Pearl is rapidly advancing a pipeline of products including PT003, an inhaled, fixed-dose combination bronchodilator product comprised of a long-acting muscarinic antagonist (LAMA) and a long-acting beta-2 agonist (LABA) delivered via a metered dose inhaler (HFA MDI); and PT010, a triple-combination product that combines the LAMA and LABA components of PT003 with an inhaled corticosteroid (ICS) for twice-daily administration from an HFA MDI for the treatment of severe COPD. Both PT003 and PT001 are developed with Pearl's proprietary porous particle cosuspension technology, which allows the formulation of multiple products in the MDI format, with highly stable, robust and aerodynamically efficient drug delivery. Founded in 2006, Pearl Therapeutics is privately held and backed by 5AM Ventures, Clarus Ventures, New Leaf Ventures and Vatera Healthcare. For more information, please visit www.pearltherapeutics.com.

* FEV1 (forced expiratory volumes in one second) is a common measurement of lung function in patients with asthma, cystic fibrosis, and COPD and is typically used to predict the severity of pulmonary disease. AUC (area under the curve) is a measure of therapeutic benefit over a period of time.

Editor's note: Spiriva® HandiHaler® (tiotropium bromide inhalation powder) is a registered trademark of Boehringer Ingelheim Pharmaceuticals; Foradil® is a registered trademark of Astellas Pharma; and Aerolizer® is a registered trademark of Novartis AG.


'/>"/>
SOURCE Pearl Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
2. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
3. Pearl Therapeutics Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD
4. Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
5. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
6. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
7. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
8. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
9. Afraxis Enters Collaboration with NIH as Part of Therapeutics for Rare and Neglected Disease Program
10. Reed V. Tuckson, M.D., Executive Vice President and Chief of Medical Affairs at UnitedHealth Group, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
11. Prime Therapeutics Launches CareCentered Contracting™ Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... YORK , May 22, 2013 While ... their teens, friends to drink at home under adult ... about drinking, the truth is that there are serious ... Partnership at Drugfree.org and The Treatment Research ... new, interactive web resource for parents and caregivers to ...
(Date:5/22/2013)... 2013 PRNewswire – iBio, Inc. (NYSE ... vaccine candidate for the newly emerged H7N9 influenza ... the iBioLaunch™ platform. This validation milestone was achieved ... sequence information to purification of recombinant protein. ... The iBioLaunch platform eliminates the need to ...
(Date:5/22/2013)... 22, 2013 WomanCare Global recently launched ... an extensive training initiative attended by 90 health ... ) (Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) Simplant, ... highly effective subdermal implant composed of two thin, ... (a synthetic form of the hormone progestin). These ...
Breaking Medicine Technology:Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 2Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 3Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 4Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 5Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 6Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 7iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2
... SAN DIEGO, Feb. 3, 2011 Neurocrine Biosciences, Inc. (Nasdaq: ... report its fourth quarter and year-end 2010 financial results after ... will then host a live conference call and webcast to ... afternoon, February 10, 2011 at 5:00 p.m. Eastern Time (2:00 ...
... 2011 SkinMedica, Inc., the fastest-growing professional skin ... that it is introducing a new, fast-acting anti-redness ... in over two decades.  It is the first ... visible redness.     (Photo: ...
Cached Medicine Technology:SkinMedica Launches Redness Relief CalmPlex™ 2SkinMedica Launches Redness Relief CalmPlex™ 3
(Date:5/22/2013)... 22, 2013 According to the National ... disorder effecting up to 3 million people in the ... the small intestine and mal-absorption of nutrients(2). To protect ... constipation, weight loss and vitamin deficiency, people with celiac ... are many gluten-free foods that celiac sufferers can eat, ...
(Date:5/22/2013)... 2013: New research shows that craving drugs such ... of the brain that are implicated in determining ... in motivation. Dr. Alain Dagher, from McGill ... regions could underlie addiction. These results were presented ... meeting of the Canadian Association for Neuroscience - ...
(Date:5/22/2013)... May 22 (HealthDay News) -- Roughly four in 10 ... pulmonary disease (COPD) actually do not have the lung ... Faulty diagnoses were made based on an evaluation of ... standard" disease test known as spirometry, which shows how ... amount of air they can exhale and how long ...
(Date:5/22/2013)... University of Melbourne said this small increase in cancer ... CT scans in diagnosing and monitoring disease. , The ... Journal today and involved researchers at eight other ... for Research on Cancer in Lyon, France. , ... providing detailed three dimensional pictures to diagnose or exclude ...
(Date:5/22/2013)... King of Prussia, PA (PRWEB) May 22, 2013 ... is proud to announce its participation in the Greater Philadelphia ... experienced cyclists and recreational riders who are passionate about stopping ... affects more than 25 million Americans. , The Tour ... Ambler Campus, located at 580 Meetinghouse Road in Ambler, 30 ...
Breaking Medicine News(10 mins):Health News:During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula 2Health News:During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula 3Health News:Addiction as a disorder of decision-making 2Health News:COPD May Be Over-Diagnosed Among Uninsured 2Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3
... Md., May 5 /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex" ... a leading independent American,provider of Western healthcare products ... announced that the Company is scheduled to participate ... held May 19-21, 2009, at,300 Madison Avenue in ...
... to Hydroxycut?DEERFIELD BEACH, Fla., May 5 The ... body blow on Friday when the FDA declared ... unsafe for human consumption and warned users to ... were taking Hydroxycut.With increasing awareness that being even ...
... New Survey From National Ovarian Cancer Coalition Says Gynecologic ... To Economic FactorsDALLAS, May 5 At Mother,s Day, ... (NOCC), www.ovarian.org , reveals some startling ... women expect the economy will impact their gynecological health ...
... The Better Hearing Institute (BHI) launched today a public ... Up in a Down Economy. The campaign focuses on ... opportunities. BHI is encouraging people of all ages who ... their jobs to make sure that unaddressed hearing loss ...
... nearly Free Tuesdays, Stonebrook Manor in Thornton, CO is offering a limited ... wedding reception hall. Rules and Restrictions apply, visit www.stonebrookmanor.com ... ... or not, the dreams of a little girl of her wedding day ...
... of growth plate injuries is key to putting an adolescent athlete back ... issue of Sports Health: A Multidisciplinary Approach. , ... Rosemont, IL (Vocus) ... is key to putting an adolescent athlete back in the game, according ...
Cached Medicine News:Health News:Chindex International, Inc. Announces May Conference Participation 2Health News:Dieters Dealt a Body Blow From Recent Labeling of Hydroxycut as Unsafe for Human Consumption 2Health News:Women's Gynecological Exams: Another Victim of the Troubled Economy? 2Health News:Listening Up in a Down Economy: Better Hearing Institute Launches Public Service Campaign for Better Hearing and Speech Month 2Health News:Listening Up in a Down Economy: Better Hearing Institute Launches Public Service Campaign for Better Hearing and Speech Month 3Health News:Stonebrook Manor Gives Away Luxurious Wedding Receptions in Colorado 2Health News:Stonebrook Manor Gives Away Luxurious Wedding Receptions in Colorado 3Health News:Adolescent Growth Plate Injuries May Be Related to Overuse 2
... BODI™ Dynamic Orthosis is the dynamic way ... over time is proven effective in reducing ... the time of other therapies. Can also ... For all joint stiffness and soft tissue ...
... The Infrapatellar Band uses ... on the patellar tendon helping ... Schlatter and patella tendonitis. Focusing ... the tibial tubercle with less ...
... Provides shoulder ... range of motion ... rotator cuff tears, ... The shoulder brace ...
Shoulder Subluxation Inhibitor (SSI) is an ideal bracing system to keep athletes on the field by reducing the risk of shoulder injury. The SSI is the only brace that allows TOTAL ANTERIOR RANGE OR MO...
Medicine Products: